Sipeimine

CAS No. 61825-98-7

Sipeimine( Kashmirine | Sipeimine )

Catalog No. M18907 CAS No. 61825-98-7

Sipeimine has antiasthmatic effect, on tracheal M receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 In Stock
10MG 200 In Stock
25MG 338 In Stock
50MG 498 In Stock
100MG 710 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sipeimine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sipeimine has antiasthmatic effect, on tracheal M receptor antagonist.
  • Description
    Imperialine is a compound in the traditional Chinese medicine chuanbeimu (Bulbus Fritillariae Cirrhosae) that has been used as antitussive/expectorant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Kashmirine | Sipeimine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    61825-98-7
  • Formula Weight
    429.64
  • Molecular Formula
    C27H43NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 8.33 mg/mL (19.39 mM)
  • SMILES
    CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O
  • Chemical Name
    Cevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sepin-1

    Sepin-1 is a noncompetitive inhibitor of separase with an IC50 of 14.8 μM. Sepin-1 can inhibit the growth of breast cancer xenograft tumors in mice and human cancer cell lines by inhibiting cell proliferation and inducing apoptosis.

  • Bragsin2

    Bragsin2 is a hydration-resistant cell penetrant, selective and non-competitive inhibitor of Afr guanine nucleotide exchange factor BRAG2.

  • 4-phenoxypiperidine

    4-phenoxypiperidines with muscle relaxant and anticonvulsant activities.